Lifitegrast
2 NDCs across 2 manufacturers|0 Generic,2 Brand
Lifitegrast is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 11, 2016, and the first generic was approved Aug 4, 2023. In 2024, Medicare Part D spent $505 million on Lifitegrast across 477,000 claims for 166,000 beneficiaries.
Lifitegrast is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $11.83 to $11.83 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
2
competing in market
Price Spread
$11.83 – $11.83
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novartis Pharmaceuticals Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing LIFITEGRAST
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XIIDRA 5% EYE DROPS | $11.8320 per EA | +0.01% |
XIIDRA 5% EYE DROPS | $11.8320 per EA | +0.01% |
Frequently Asked Questions
What is Lifitegrast used to treat?
Lifitegrast is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
When did Lifitegrast become available as a generic?
FDA approved the first generic Lifitegrast (ANDA) on Aug 4, 2023.
How much does Medicare spend on Lifitegrast?
In 2024, Medicare Part D spent $505 million on Lifitegrast across 477,000 claims for 166,000 beneficiaries.
How many Lifitegrast products are on the market?
The Lifitegrast drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.
What is the price range for Lifitegrast?
NADAC reference prices for Lifitegrast range from $11.8320 to $11.8320 per EA.
Which manufacturers make Lifitegrast?
2 manufacturers list Lifitegrast in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (1), Bausch & Lomb Incorporated (1).
How has the price of Lifitegrast changed recently?
Over the past 7 days, 2 Lifitegrast NDCs rose and 0 fell, with a market-wide average change of +0.0%.